Healthcare Cold Chain Third Party Logistics Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Healthcare cold chain third-party logistics encompasses specialized services for transporting and storing temperature-sensitive medical products within a controlled temperature range, typically between 2°C and 8°C for refrigerated items and -20°C to -70°C for frozen products. The market includes services for vaccines, biopharmaceuticals, clinical trial materials, and other temperature-sensitive healthcare products across the pharmaceutical and medical device industries. The U.S. healthcare logistics market alone was valued at $28.92 billion in 2025 and is expected to reach $61.45 billion by 2035.

• •Market valued at $96.15 billion globally in 2025, projected to reach $250.17 billion by 2035
• •Services include transportation, warehousing, packaging, and inventory management for temperature-sensitive products
• •Key product categories: vaccines, biopharmaceuticals, clinical trial materials, and other specialty healthcare products

The rapid expansion of biologic and biosimilar drug pipelines has significantly increased demand for cold chain logistics, as these therapies often require storage at specific temperatures throughout the supply chain. Global vaccination initiatives and pandemic preparedness efforts continue to drive investment in cold chain infrastructure, particularly in emerging markets. Additionally, the rise of personalized medicine and cell and gene therapies, which frequently require ultra-cold storage, creates new opportunities for specialized logistics providers.

• •Growing production and distribution of biologics and biosimilars requiring 2-8°C or ultra-cold storage
• •Expanding vaccine development and immunization programs worldwide
• •Increasing regulatory requirements and quality standards for pharmaceutical product integrity

The market is segmented by industry type, including biopharmaceuticals, pharmaceuticals, and medical devices, with cold chain logistics further divided into services such as transportation, storage, and packaging. Product categories span vaccines, biopharmaceuticals, clinical trial materials, and others. North America currently leads the market due to advanced healthcare infrastructure, while Asia-Pacific is experiencing the fastest growth driven by pharmaceutical manufacturing expansion and improving healthcare access.

• •Primary segmentation by industry: biopharmaceutical, pharmaceutical, and medical device sectors
• •Service types include storage, transportation, packaging, and inventory management
• •North America dominates market share, with Asia-Pacific showing highest growth rate

What are the recent trends and outlook?

Digitalization and IoT-enabled temperature monitoring are transforming cold chain logistics, with real-time tracking and predictive analytics becoming standard offerings. The growing importance of last-mile delivery for specialty drugs and vaccines is driving investment in specialized packaging solutions and local distribution networks. Sustainability initiatives, including reusable packaging and carbon-neutral transportation, are gaining prominence as pharmaceutical companies commit to reducing supply chain emissions. The market is expected to maintain strong growth through 2035 as biologics and personalized medicine continue to gain market share.

• •IoT sensors and blockchain technology improving supply chain visibility and compliance
• •Increasing adoption of reusable and sustainable cold chain packaging solutions
• •Growing demand for last-mile delivery capabilities for specialty pharmacy and home healthcare products